Clinicians should be reassured that patients with obesity and on antidepressants who don t have major depressive disorder or suicidality in the past 2 years can receive semaglutide, says a researcher.
Pediatric obesity is a serious disease and its prevalence has increased during the COVID-19 pandemic. Many factors can contribute to excess weight gain in youth including genetics/biology, the obesogenic environment, stress and sleep routines.
/PRNewswire/ Obesity in pediatric patients is a serious disease with one in five children living with the condition. Compared with children with normal.